Abstract: Disclosed are compounds that are agonists or antagonists of the S1P5 receptor, compositions comprising said compounds, and methods of using said compounds and compositions. In certain embodiments, said compounds are l-benzylazetidine-3-carboxylic acid derivatives. In certain embodiments, said methods relate to the treatment of neuropatic pain and/or a neurodegenerative disorder. In certain embodiments, said compounds may be used in combination with a second therapeutic agent.
NA
| # | Name | Date |
|---|---|---|
| 1 | 5462-delnp-2011-Abstract.pdf | 2012-03-04 |
| 1 | 5462-delnp-2011-Form-3-(18-01-2012).pdf | 2012-01-18 |
| 2 | 5462-delnp-2011-Correspondence-Others-(18-01-2012).pdf | 2012-01-18 |
| 2 | 5462-delnp-2011-Assignment.pdf | 2012-03-04 |
| 3 | 5462-delnp-2011-GPA.pdf | 2012-03-04 |
| 3 | 5462-delnp-2011-Claims.pdf | 2012-03-04 |
| 4 | 5462-delnp-2011-Form-5.pdf | 2012-03-04 |
| 4 | 5462-delnp-2011-Correspondence-others.pdf | 2012-03-04 |
| 5 | 5462-delnp-2011-Description (Complete).pdf | 2012-03-04 |
| 5 | 5462-delnp-2011-Form-3.pdf | 2012-03-04 |
| 6 | 5462-delnp-2011-Form-1.pdf | 2012-03-04 |
| 6 | 5462-delnp-2011-Form-2.pdf | 2012-03-04 |
| 7 | 5462-delnp-2011-Form-1.pdf | 2012-03-04 |
| 7 | 5462-delnp-2011-Form-2.pdf | 2012-03-04 |
| 8 | 5462-delnp-2011-Description (Complete).pdf | 2012-03-04 |
| 8 | 5462-delnp-2011-Form-3.pdf | 2012-03-04 |
| 9 | 5462-delnp-2011-Correspondence-others.pdf | 2012-03-04 |
| 9 | 5462-delnp-2011-Form-5.pdf | 2012-03-04 |
| 10 | 5462-delnp-2011-GPA.pdf | 2012-03-04 |
| 10 | 5462-delnp-2011-Claims.pdf | 2012-03-04 |
| 11 | 5462-delnp-2011-Correspondence-Others-(18-01-2012).pdf | 2012-01-18 |
| 11 | 5462-delnp-2011-Assignment.pdf | 2012-03-04 |
| 12 | 5462-delnp-2011-Form-3-(18-01-2012).pdf | 2012-01-18 |
| 12 | 5462-delnp-2011-Abstract.pdf | 2012-03-04 |